Literature DB >> 20813551

Is cognitive functioning 1 year poststroke related to quality of life domain?

Clara L M Verhoeven1, Marcel W M Post, Sven K Schiemanck, Martine J E van Zandvoort, Peter H Vrancken, Caroline M van Heugten.   

Abstract

Previous studies on the association between poststroke cognitive impairment and quality of life (QoL) have shown divergent results. In this study, we investigated the relationships between cognitive functioning and various QoL domains at 1 year poststroke. This was a cross-sectional study, examining 92 patients at 1 year poststroke. Cognitive functioning was measured with a neuropsychological test battery covering language, attention and psychomotor function, memory, visuoperception, and neglect. QoL domains were functional independence (Barthel Index), social participation (Frenchay Activities Index), depressive mood (Center for Epidemiological Studies Depression Scale), and life satisfaction (Life Satisfaction Questionnaire). Bivariate and multivariate relationships between cognitive and QoL variables were analyzed, the latter both with and without controlling for demographic variables and motor impairment. The prevalence of cognitive impairments varied between 19.3% (neglect) and 72% (attention and psychomotor function). Correlations between cognitive functioning and QoL were strongest for social participation (0.41-0.60, P < .01) and functional independence (0.13-0.58, P < .05). The percentages of variance explained by the total cognition score were 19% for functional independence, 40% for participation, 8% for life satisfaction, and 5% for depression. Controlling for demographic factors and motor impairments resulted in negligible percentages of variance additionally explained by cognitive functioning. The percentages of explained variance were somewhat lower in the analyses with the separate cognitive domains and not significant for depression. Poor cognitive functioning was associated with reduced functional independence, social participation, depressive mood, and life satisfaction 1 year post; however, motor impairment was a stronger determinant of long-term QoL than cognitive functioning.
Copyright © 2011 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20813551     DOI: 10.1016/j.jstrokecerebrovasdis.2010.02.018

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Impact of brain tumor location on morbidity and mortality: a retrospective functional MR imaging study.

Authors:  J M Wood; B Kundu; A Utter; T A Gallagher; J Voss; V A Nair; J S Kuo; A S Field; C H Moritz; M E Meyerand; V Prabhakaran
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

2.  Normative data for distal line bisection and baking tray task.

Authors:  Alessio Facchin; Nicoletta Beschin; Alessia Pisano; Cristina Reverberi
Journal:  Neurol Sci       Date:  2016-06-03       Impact factor: 3.307

3.  Responsiveness, Minimal Clinically Important Difference, and Validity of the MoCA in Stroke Rehabilitation.

Authors:  Ching-Yi Wu; Shuan-Ju Hung; Keh-Chung Lin; Kai-Hua Chen; Poyu Chen; Pei-Kwei Tsay
Journal:  Occup Ther Int       Date:  2019-04-14       Impact factor: 1.448

4.  Predicting functional outcome after stroke: the influence of neglect on basic activities in daily living.

Authors:  Tanja Nijboer; Ingrid van de Port; Vera Schepers; Marcel Post; Anne Visser-Meily
Journal:  Front Hum Neurosci       Date:  2013-05-09       Impact factor: 3.169

5.  The effect of non-elastic taping on balance and gait function in patients with stroke.

Authors:  Chan-Woo Nam; Jung-Ho Lee; Sung-Hyoun Cho
Journal:  J Phys Ther Sci       Date:  2015-09-30

6.  Acupuncture improves cognitive function: A systematic review.

Authors:  Mason Chin Pang Leung; Ka Keung Yip; Chung Tsung Lam; Ka Shun Lam; Wai Lau; Wing Lam Yu; Amethyst King Man Leung; Kwok-Fai So
Journal:  Neural Regen Res       Date:  2013-06-25       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.